VacZine Analytics  
MarketVIEW: Rabies vaccines

Published: March 2014

Rabies is a viral zoonosis caused by all members of the Lyssavirus genus and mostly spread by canine vectors. The disease, if untreated is 100% fatal, although almost 100% preventable through timely postexposure prophylaxis (PEP). Rabies causes tens of thousands of deaths each year, mainly in rural areas of Africa and Asia.

Novartis Vaccines and Sanofi are the only Western producers vaccines for rabies with Rabavert/Rabipur and Verorab/Imovax products respectively. Several domestic vaccine manufacturers (DVMs) in China, India and Russia produce rabies vaccines which serve domestic demand; some also export rabies vaccine. China is the largest market for rabies vaccines.

This MarketVIEW product is a comprehensive commercial opportunity assessment detailing the potential market for rabies vaccine(s) using a patient based value/volume forecast for major rabies endemic markets to 2024. The forecast gives revenues and volume shares for Western competitors in both pre-and postexposure markets. The analysis takes into account the use of different PEP regimens (ID/IM), current/future market trends and gives an up-to-date review of competitor dynamics, and disease epidemiology.

THIS PRODUCT IS A SUMMARY PRESENTATION + 1 MODEL

To order please contact your region account manager, buy "on-line" or order direct at: orders@vaczine-analytics.com

CAT No: CONTENTS: PURCHASE:
VAMV055 Click here>>
Choose option:
*Prices quotes are for 1 region license only. Regions are North America, or EU or ROW. For UK orders VAT will be added at 20%. Please review the TERMS and CONDITIONS of purchase.

Return to main list>> Questions about this report?






© 2014 VacZine Analytics. All rights reserved. Disclaimer | Privacy | Terms and conditions. hosted by chillydomains